Ethyl 2,5-dimethyl-4-oxo-2-(thiophen-2-yl)-1,2,3,4-tetrahydrothieno[3,4-d]pyrimidine-7-carboxylate

Catalog No. :
ACSQFC852
CAS No. :
381203-81-2
Molecular Formula :
C15H16N2O3S2
Molecular Weight :
336.44

IUPAC Name:ethyl 2,5-dimethyl-4-oxo-2-(thiophen-2-yl)-1,2,3,4-tetrahydrothieno[3,4-d]pyrimidine-7-carboxylate

Ethyl 2,5-dimethyl-4-oxo-2-(thiophen-2-yl)-1,2,3,4-tetrahydrothieno[3,4-d]pyrimidine-7-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2,5-dimethyl-4-oxo-2-(thiophen-2-yl)-1,2,3,4-tetrahydrothieno[3,4-d]pyrimidine-7-carboxylate
IUPAC Nameethyl 2,5-dimethyl-4-oxo-2-(thiophen-2-yl)-1,2,3,4-tetrahydrothieno[3,4-d]pyrimidine-7-carboxylate
Molecular FormulaC15H16N2O3S2
Molecular Weight336.44
SMILESO=C(C1=C(C2=C(C)S1)NC(C3=CC=CS3)(C)NC2=O)OCC
InChI KeyUGUSFEIFDZORLU-UHFFFAOYSA-N
Synonymethyl 2,5-dimethyl-4-oxo-2-thiophen-2-yl-1,3-dihydrothieno[3,4-d]pyrimidine-7-carboxylate;Thieno[3,4-d]pyrimidine-7-carboxylic acid, 1,2,3,4-tetrahydro-2,5-dimethyl-4-oxo-2-(2-thienyl)-, ethyl ester
CAS No.381203-81-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACSQFC852 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSQFC852 route product structure diagram
    ACSQFC852381203-81-2
Inquiry

2. ACSQFC852 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSQFC852 route product structure diagram
    ACSQFC852381203-81-2
Inquiry

Comments (0)